(Q51932203)

English

An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations.

scientific article published in May 2007

In more languages
default for all languages
No label defined

No description defined

Statements

An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit